Report Overview
Injectable Bone Putty is a biocompatible material primarily utilized in orthopedic and dental procedures for bone repair and regeneration. This innovative material is designed to enhance bone healing by filling voids or defects, acting as a scaffold that supports new bone growth. Injectable Bone Putty is widely used in surgeries involving fractures, bone loss, and reconstructive procedures, providing an effective alternative to traditional bone grafting methods. The material is engineered to be moldable, bioabsorbable, and compatible with the body, minimizing the risk of adverse reactions and ensuring successful integration.
Market Shares
The global Injectable Bone Putty market was valued at approximately USD 168 million in 2024 and is expected to reach USD 271.84 million by 2032, exhibiting a compound annual growth rate (CAGR) of 6.20% during the forecast period.
North America accounted for a significant share of the market, with an estimated valuation of USD 48.55 million in 2024, growing at a CAGR of 5.31% through 2032.
Medtronic
Key Company
Stryker (Wright Medical)
BONESUPPORT
Xtant Medical
SeaSpine
Zimmer Biomet
Market Segmentation (by Application) Orthopedics – The largest segment, driven by increasing cases of fractures and orthopedic surgeries.
Dental – Growing use in dental bone grafting and maxillofacial procedures.
• Market Segmentation (by Type)
DBM Putty – A widely used demineralized bone matrix putty with high osteoinductive properties.
Others – Includes synthetic and allograft-based putties.
Geographic Segmentation
• North America: USA, Canada, Mexico
• Europe: Germany, UK, France, Russia, Italy, Rest of Europe
• Asia-Pacific: China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific
• South America: Brazil, Argentina, Colombia, Rest of South America
• Middle East and Africa: Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA
https://www.statsmarketresearch.com/global-injectable-
